Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.22
Delayed Data
As of 4:00pm ET
 +0.01 / +0.24%
Today’s Change
2.96
Today|||52-Week Range
29.94
-73.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues11.2M4.1M3.6M5.5M
 
 
 
 
 
Cost of Goods Sold8.7M2.3M0.000.00
 
 
 
Depreciation And Amortization3.1M2.9M3.4M4.0M
 
 
 
 
 
 
Operating ExpensesGross Income-663.0K-1.2M185.0K1.5M
 
 
 
 
 
General Expenses57.4M80.3M122.6M131.0M
 
 
 
 
 
Research And Development47.4M65.5M102.0M100.2M
 
 
 
 
 
Total Operating Expenses69.3M85.6M126.0M135.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-58.1M-81.4M-122.4M-129.5M
 
 
 
 
 
Interest Expense On Debt1.6M927.0K0.000.00
 
 
 
Other Expenses100.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-59.1M-81.6M-118.1M-127.2M
 
 
 
 
 
Net Income-59.1M-81.6M-118.1M-127.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.7M79.8M89.4M97.1M
 
 
 
 
 
Shares To Calculate EPS Diluted57.7M79.8M89.4M97.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.02-$1.02-$1.32-$1.31
 
 
 
 
 
EPS Diluted-$1.02-$1.02-$1.32-$1.31